• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRKL通过ERK-MMP9途径促进肺癌细胞侵袭。

CRKL promotes lung cancer cell invasion through ERK-MMP9 pathway.

作者信息

Lin Fu, Chengyao Xie, Qingchang Li, Qianze Dong, Enhua Wang, Yan Wang

机构信息

Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning, China.

出版信息

Mol Carcinog. 2015 Jun;54 Suppl 1:E35-44. doi: 10.1002/mc.22148. Epub 2014 Mar 24.

DOI:10.1002/mc.22148
PMID:24664993
Abstract

CRKL is recently defined as a new oncogene, which plays a role in the lung cancer progression. However, the potential mechanism of CRKL in human non-small cell lung cancer cell invasion is obscure. We investigated the potential mechanism of CRKL in lung cancer cell invasion using immunohistochemistry, plasmid transfection, Western blotting, real-time PCR, matrigel invasion assay, chromatin immunoprecipitation assay, and luciferase reporter assay. CRKL expression is higher in lymph node metastatic tumor compared with primary tumor. CRKL overexpression enhanced cell invasion and MMP9 expression in both HBE and H1299 cell lines. There was a significant correlation between CRKL overexpression and high MMP9 expression in primary tumors. MMP-9 antibody treatment significantly blocked cell invasion. CRKL overexpression also activated AP-1 luciferase reporter activity, ERK phosphorylation and association of c-fos to MMP9 promoter. Treatment with ERK inhibitor PD98059 in cells with CRKL transfection inhibited ERK activity, cell invasion, and MMP9 expression. These results suggested that overexpression of CRKL promoted cell invasion through upregulation of MMP9 expression and activation of ERK pathway.

摘要

CRKL最近被定义为一种新的癌基因,它在肺癌进展中发挥作用。然而,CRKL在人类非小细胞肺癌细胞侵袭中的潜在机制尚不清楚。我们使用免疫组织化学、质粒转染、蛋白质免疫印迹、实时聚合酶链反应、基质胶侵袭试验、染色质免疫沉淀试验和荧光素酶报告基因试验,研究了CRKL在肺癌细胞侵袭中的潜在机制。与原发性肿瘤相比,CRKL在淋巴结转移瘤中的表达更高。CRKL过表达增强了HBE和H1299细胞系中的细胞侵袭和MMP9表达。原发性肿瘤中CRKL过表达与高MMP9表达之间存在显著相关性。MMP-9抗体处理显著阻断细胞侵袭。CRKL过表达还激活了AP-1荧光素酶报告基因活性、ERK磷酸化以及c-fos与MMP9启动子的结合。在转染CRKL的细胞中用ERK抑制剂PD98059处理可抑制ERK活性、细胞侵袭和MMP9表达。这些结果表明,CRKL过表达通过上调MMP9表达和激活ERK途径促进细胞侵袭。

相似文献

1
CRKL promotes lung cancer cell invasion through ERK-MMP9 pathway.CRKL通过ERK-MMP9途径促进肺癌细胞侵袭。
Mol Carcinog. 2015 Jun;54 Suppl 1:E35-44. doi: 10.1002/mc.22148. Epub 2014 Mar 24.
2
Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.Derlin-1 在非小细胞肺癌中过表达,并通过 EGFR-ERK 介导的 MMP-2 和 MMP-9 的上调促进癌细胞侵袭。
Am J Pathol. 2013 Mar;182(3):954-64. doi: 10.1016/j.ajpath.2012.11.019. Epub 2013 Jan 7.
3
CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.CrkL通过Ras和Rac在SDF-1诱导的Raf-1/MEK/Erk信号通路激活中发挥作用,从而介导造血细胞中的趋化信号。
Cell Signal. 2006 Dec;18(12):2162-71. doi: 10.1016/j.cellsig.2006.05.001. Epub 2006 May 16.
4
Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.CRKL 过表达与非小细胞肺癌不良预后和细胞增殖相关。
Mol Carcinog. 2013 Nov;52(11):890-9. doi: 10.1002/mc.21935. Epub 2012 Jun 29.
5
Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.基质金属蛋白酶-9参与肺癌转移的基质细胞衍生因子-1/CXCR4通路
Carcinogenesis. 2008 Jan;29(1):35-43. doi: 10.1093/carcin/bgm220. Epub 2007 Oct 4.
6
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.RNAi 介导的 VEGF-C 沉默通过同时下调 CXCR4、CCR7、VEGFR-2 和 VEGFR-3 依赖性轴诱导的 ERK、p38 和 AKT 信号通路抑制非小细胞肺癌的进展。
Eur J Cancer. 2011 Oct;47(15):2353-63. doi: 10.1016/j.ejca.2011.05.006. Epub 2011 Jun 15.
7
Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.Bcl-2通过诱导基质金属蛋白酶-2促进侵袭和肺转移。
Cancer Res. 2005 Jul 1;65(13):5554-60. doi: 10.1158/0008-5472.CAN-04-4570.
8
Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.SIRT6的上调预示着非小细胞肺癌的预后不良,并通过ERK1/2/MMP9途径促进其转移。
Oncotarget. 2016 Jun 28;7(26):40377-40386. doi: 10.18632/oncotarget.9750.
9
KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.在H1299人肺癌细胞系中,KAI1/CD82通过上调TIMP1使MMP9失活,从而抑制肿瘤侵袭。
Biochem Biophys Res Commun. 2006 Apr 7;342(2):655-61. doi: 10.1016/j.bbrc.2006.01.153. Epub 2006 Feb 8.
10
miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway.miR-429-CRKL 轴通过 SOS1/MEK/ERK/MMP2/MMP9 通路调控肾透明细胞癌恶性进展。
Biomed Pharmacother. 2020 Jul;127:110215. doi: 10.1016/j.biopha.2020.110215. Epub 2020 May 12.

引用本文的文献

1
Vitamin D-mediated tsRNA-07804 triggers mitochondrial dysfunction and suppresses non-small cell lung cancer progression by targeting CRKL.维生素 D 介导的 tsRNA-07804 通过靶向 CRKL 触发线粒体功能障碍并抑制非小细胞肺癌进展。
J Cancer Res Clin Oncol. 2024 Jan 30;150(2):51. doi: 10.1007/s00432-023-05586-1.
2
USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL.USP53通过去泛素化CRKL在三阴性乳腺癌中发挥促肿瘤作用。
Cancers (Basel). 2023 Oct 18;15(20):5033. doi: 10.3390/cancers15205033.
3
Research Advances in the Role of the Tropomyosin Family in Cancer.
原肌球蛋白家族在癌症中的作用的研究进展。
Int J Mol Sci. 2023 Aug 27;24(17):13295. doi: 10.3390/ijms241713295.
4
CCL2 promotes proliferation, migration and angiogenesis through the MAPK/ERK1/2/MMP9, PI3K/AKT, Wnt/β‑catenin signaling pathways in HUVECs.CCL2通过MAPK/ERK1/2/MMP9、PI3K/AKT、Wnt/β-连环蛋白信号通路促进人脐静脉内皮细胞(HUVECs)的增殖、迁移和血管生成。
Exp Ther Med. 2022 Dec 27;25(2):77. doi: 10.3892/etm.2022.11776. eCollection 2023 Feb.
5
PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway.PPP1R14D 通过 PKCα/BRAF/MEK/ERK 信号通路促进肺腺癌的增殖、迁移和侵袭。
Int J Oncol. 2022 Dec;61(6). doi: 10.3892/ijo.2022.5443. Epub 2022 Oct 20.
6
Proteomic and functional characterization of intra-tumor heterogeneity in human endometrial cancer.人类子宫内膜癌肿瘤内异质性的蛋白质组学和功能特征。
Cell Rep Med. 2022 Sep 20;3(9):100738. doi: 10.1016/j.xcrm.2022.100738. Epub 2022 Sep 13.
7
Tumor suppressor p53 restrains cancer cell dissemination by modulating mitochondrial dynamics.肿瘤抑制因子p53通过调节线粒体动力学来抑制癌细胞扩散。
Oncogenesis. 2022 May 19;11(1):26. doi: 10.1038/s41389-022-00401-x.
8
Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.肢端黑色素瘤的综合分子与临床特征分析提示 22q11.21 局灶扩增与转移相关。
Nat Commun. 2022 Feb 23;13(1):898. doi: 10.1038/s41467-022-28566-4.
9
TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9.TPM3通过MMP2/MMP9介导食管癌中的上皮-间质转化。
Ann Transl Med. 2021 Aug;9(16):1338. doi: 10.21037/atm-21-4043.
10
Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype.散发性脑动静脉畸形中 MAPK 通路的体体细胞嵌合体与表型的关联。
J Neurosurg. 2021 Jul 2;136(1):148-155. doi: 10.3171/2020.11.JNS202031. Print 2022 Jan 1.